← Back to Search

Vitamin

Arm A: Healthy Collegiate Athletes for Traumatic Brain Injury (TRMC-004 Trial)

N/A
Waitlist Available
Led By Brent A Bauer, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, day 84
Awards & highlights

TRMC-004 Trial Summary

This study is evaluating whether a vitamin may help improve memory and thinking skills in older adults.

Eligible Conditions
  • Traumatic Brain Injury

TRMC-004 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, day 84
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, day 84 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in brain NAD+ levels

TRMC-004 Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Arm A: Healthy Collegiate AthletesActive Control1 Intervention
Healthy collegiate athletes will take active Nicotinamide Riboside
Group II: Arm B: Healthy Collegiate AthletesPlacebo Group1 Intervention
Healthy collegiate athletes will take a matching placebo

Find a Location

Who is running the clinical trial?

Thorne HealthTech, IncIndustry Sponsor
10 Previous Clinical Trials
650 Total Patients Enrolled
Mayo ClinicLead Sponsor
3,205 Previous Clinical Trials
3,766,754 Total Patients Enrolled
University of MinnesotaOTHER
1,377 Previous Clinical Trials
1,588,266 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~3 spots leftby Apr 2025